The authors of “Evaluation of a New Model of Care for People with Complications of Diabetic Retinopathy: The EMERALD Study” (Ophthalmology 2021;128(4):561-573) would like to make the following corrections to their article (changes in bold):
In the Abstract’s Purpose section, the last sentence should read:
“EMERALD tested diagnostic accuracy, acceptability, and costs of a new health care pathway for people with previously successfully treated DME and/or PDR.”
In the Methods section of the main manuscript, the last sentence of the first paragraph should read:
The EMERALD study was funded by the Health Technology Assessment of the National Institute for Health Research in the United Kingdom (identifier, 15/42/08).